Bharat Book Bureau Provides the Trending Market Research Report on“Global Vascular Graft Market Forecast to 2022” underLife Sciences category. The report provides information on industry overview, market size, latest developments, industry trends, Keyplayers, global presence, and their future prospects.
Global Vascular Grafts Market projected to grow at aCAGR of 7.3% during the forecast period
The vascular grafts market is expected to reachUSD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%. The major factors driving the growth of this market are the high burden of abdominal aneurysms, increasing geriatric population, and increasing prevalence of smoking & other risk factors that promote aneurysms.
The polyester segment is expected to grow at the highest growth rate during the forecast period
On the basis of raw material, the vascular grafts market is segmented into ePTFE grafts, polyester grafts, polyurethane grafts, and biosynthetic grafts. Polyester grafts are expected to grow at the highest CAGR during the forecast period. The high growth rate of the segment can be attributed to the fact that most newly launched vascular grafts are made of polyester and because the advantages it offers such as high patency, high porousness, and reduced post-surgery side effects.
Request a free sample copy ofVascular GraftMarket Report @ https://www.bharatbook.com/request-sample/992067
The endovascular aneurysm repair segment is estimated to grow at the highest CAGR during the forecast period
On the basis of indication, the vascular grafts market is classified into endovascular aneurysm repair or EVAR, hemodialysis access, and peripheral vascular aneurysm. The endovascular aneurysm repair segment is estimated to grow at the highest CAGR during the analysis period. The growth of this segment is mainly driven by the rising adoption of endovascular aneurysm repair surgical procedures, increasing preference for minimally invasive surgical procedures over open surgeries, and growing geriatric population.
Asia Pacific is estimated to grow at the highest CAGR during the study period
Geographically, the vascular grafts market is dominated by North America, followed by Europe in 2017, however, Asia Pacific is estimated to grow at the fastest rate during the forecast period. Growth in the APAC region can be attributed to the rising prevalence of chronic kidney disease, healthcare reforms, government initiatives and investments, and rapid growth in geriatric population. Emerging markets in the region, such as Australia, Singapore, Japan, and China also offer numerous growth opportunities for players operating in the vascular grafts.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type - Tier 1 – 60% and Tier 2 – 40%
- By Designation – C level – 62%, Director level – 21%, Others – 17%
- By Region – North America – 50%, Europe – 20%, Asia – 30%
The key players operating in this market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US).
To browse full research report with TOC, click the link below :
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Follow us on: Twitter, Facebook, LinkedIn, Google Plus
**Disclaimer:The news, reports, views and opinions expressed by the Crowdfunding Platforms that are advertised at crweworld.com are their own and do not necessarily represent the views of CRWE World. Crown Equity Holdings Inc. has received $2,000.00 (two thousand dollars) in cash for 30 days of advertisement services for ChoiceTrade Holdings from Wallstreet Equities Ltd.